Company CVAbout Amrutanjan Health Care Ltd 
Amrutanjan Health Care Ltd
Small Cap
Pharmaceuticals & Drugs
Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Company Coordinates
Company Details
New 103 Old 42-45 LuzChurch Rd, Mylapore Chennai Tamil Nadu : 600004
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai
Capital StructureCapital Structure
Present Equity Capital
INR 2.89 Cr
Number of Shares
2.89 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Jul-2023
2.89
2.89
-320000
1
Buy Back of Shares
13-Apr-2018
2.92
2.92
14615315
1
Stock Split
25-Oct-2012
1.46
2.92
11692252
2
Stock Split
25-Oct-2012
1.46
2.92
11692252
2
Stock Split
08-Aug-2011
29.23
2.92
-106937
10
Buy Back of Shares
08-Aug-2011
29.23
2.92
-106937
10
Buy Back of Shares
30-Jun-2009
30.3
3.03
-71660
10
Buy Back of Shares
30-Jun-2009
30.3
3.03
-71660
10
Buy Back of Shares
31-Mar-2009
31.02
3.10
-98340
10
Buy Back of Shares
31-Mar-2009
31.02
3.10
-98340
10
Buy Back of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 5 Schemes (9.21%)
FIIs
Held by 26 FIIs (2.3%)
Promoter with highest holding
Goodhealth Holdings Private Limited (20.15%)
Highest Public shareholder
Dsp Small Cap Fund (5.07%)
Individual Investors Holdings
33.73%
Board of Directors
Management
Designation
Remuneration
S Sambhuprasad
CMD & Executive Director
1.54 cr
Marie Shiranee Pereira
Independent Non Exe. Director
4.53 lacs
V Raja
Independent Non Exe. Director
12.63 lacs
Muralidharan Swayambunathan
Independent Non Exe. Director
10.27 lacs
Meena Lochani Raghunathan
Independent Non Exe. Director
4.84 lacs
Ramaa Prabhakar Arikirevula
Non Executive Director
0
M Srinivasan.
Company Sec. & Compli. Officer
40.71 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Finished Goods
35.9892
0%
Purchase of Finished Goods
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Revenue from Discontinued Operation
0.15
0.06%
Revenue from Discontinued Operation
Revenue from Discontinued Operation
Stock DNARevenue and Profits:
Net Sales:
123 Cr
(Quarterly Results - Dec 2024)
Net Profit:
19 Cr
Pharmaceuticals & Drugs
INR 1,837 Cr (Small Cap)
37.00
33
0.73%
-0.24
16.57%
6.15
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
